Categories
Politics

Weak jobs report reveals want for enormous jobs and households payments: Biden

WASHINGTON – President Joe Biden said Friday that lower-than-expected job growth in April shows that the U.S. economy is still struggling to recover from the Covid pandemic and that its massive bills for infrastructure and family support are now more than ever needed.

“This month’s job numbers show that we are on the right track,” said Biden. “But we still have a long way to go. My laser focus is on growing the country’s economy and creating jobs. My laser focus is on vaccination, and my laser focus is on one more thing: making sure that hard-working people are in this country will no longer be left out in the cold. “

Hours before Biden spoke, the Labor Department reported that the hiring slowed dramatically in April. The number of non-farm workers rose by 266,000, significantly less than expected, and the unemployment rate rose to 6.1% due to the increasing shortage of available labor.

Dow Jones estimated 1 million new jobs and an unemployment rate of 5.8%.

Many economists had expected even higher jobs in the face of signs that the US economy was coming back to life.

Biden said the slow pace of recovery helped disprove critics of the government’s Covid relief efforts.

“Some critics said we didn’t need the American bailout plan, this economy would only heal itself. I think today’s report only underscores the importance of the measures we are taking,” said the president. “Our efforts are starting to work, but the climb is steep and we still have a long way to go.”

The unexpectedly low job growth could bolster the Biden administration’s argument to Congress that the president’s $ 4 trillion plans for jobs and families are required for the U.S. economy to fully recover from the pandemic.

Biden’s Infrastructure Bill, dubbed the American Employment Plan, would spend $ 2.3 trillion on rebuilding the country’s transportation infrastructure and create millions of jobs for workers without a college degree.

The second part of his national agenda, the American Families Plan, would provide an additional $ 1.8 trillion to fund universal preschool kindergarten to offer free community college to every American and subsidize childcare, among other things.

Biden intends to fund his stimulus packages by raising the corporate tax rate, raising taxes on the very rich, filling in loopholes, and increasing IRS enforcement.

And while the president is hoping to gain bipartisan support for the bills, Republicans in Congress have already said tax hikes are a red line they won’t cross.

Negotiations continue, however, and a group of Republican senators are expected to visit the White House in the coming days to meet with the president on possible areas of compromise.

The labor shortage debate

The weak recovery in jobs also reflects what many economists are referring to as multi-sector labor shortages.

“I think it’s as much about a lack of labor as it is a lack of labor demand,” Jason Furman, an economist at Harvard University and a former advisor to the Obama administration, told CNBC. “If you look at April, it seems like there were around 1.1 unemployed for every vacancy. So there are a lot of jobs out there, there just isn’t a lot of labor.”

Republicans and some employers have attributed the labor shortage to what they believe is overly generous unemployment benefits approved by Congress as part of the comprehensive pandemic relief package.

Specifically, they point to a $ 300 weekly unemployment bonus, over and above what states stipulate and which is slated to expire in September.

“I told you weeks ago that every day in Florida I hear from small businesses that they can’t hire people because the government is paying them to keep them out of work,” Republican Senator Marco Rubio tweeted Friday.

Biden rejected this argument. “Today’s report is a refutation of the talk that Americans just don’t want to work,” he said.

“This report shows that there is a much bigger problem: our economy still has 8 million fewer jobs than when this pandemic started.”

The president also said the impact of unemployment benefits on labor markets was “not measurable”.

Census data gathered over the past few weeks suggests that daycare and school closings have forced millions of Americans to stay home and look after children or monitor online learning.

According to a household impulse census poll conducted in late March, 6.3 million people said they were not working because they had to look after a child who was not in school or daycare. Another 2.1 million cared for an elderly person.

Another 4.1 million Americans said they were not working due to concerns about getting or spreading Covid.

— CNBC’s Jeff Cox contributed to this report.

Categories
Business

Meme Shares and Archegos: Fed Calls Out Monetary Weak Spots

The Federal Reserve warned of the financial stability risks posed by foamy stocks and debt-laden hedge fund betting in its bi-annual report on potential vulnerabilities in the system, and pointed to the surge in so-called meme stocks as a sign of risk-taking spiraling out of control .

The central bank’s financial stability report released on Thursday followed an unusual six-month period for the markets. During that period, stocks rose steadily as the US economic outlook rebounded and stories of surpluses surfaced.

Internet roundtables helped spark interest in stocks like GameStop, a cryptocurrency created as a hoax, and a little-known hedge fund melted down. These stories have made headlines, causing many – including obviously some at the Fed – to wonder if the financial system was headed for trouble.

“The security vulnerabilities associated with an increased risk appetite are increasing,” said Lael Brainard, a Fed governor, in a statement on the Fed’s release. Stock prices are high compared to earnings, and “risk-taking has risen sharply, as the” Meme Stock “episode demonstrated.”

The Fed’s new report painted a generally sunny picture with banks, consumers and businesses weathering the coronavirus shock in reasonable financial shape, and it said that some measures made risk appetite look typical.

However, the report found that some asset prices “may be susceptible to significant declines should appetite decline” and that “high volume and price volatility episodes for so-called meme stocks” are among the signs of “increased appetite for risk.” Stock markets “belong. Officials also selected hedge funds, saying the opaque investment vehicles had slightly higher than normal leverage, while warning that the data available on funds “may not capture major risks”.

The report, which took on a threatening tone at times, contrasted with the picture Fed officials, economists and investors alike have painted of the U.S. economy, which is expected to recover rapidly from the spread of coronavirus vaccines. It was emphasized that increasing consumer and business confidence can fuel risky bets and create or expand weaknesses in the financial markets.

In business today

Updated

May 7, 2021, 11:56 p.m. ET

The Fed’s suggestion that more data be needed on hedge fund debt followed an episode in March when banks were having trouble at a large fund, Archegos Capital Management. The fund had amassed large, leveraged stock bets that went bad and cost the banks with which it had done business.

“While broader market spillovers appeared limited, the episode shows the potential for material hardship” in non-bank financial firms “to” affect the broader financial system, “the Fed said in its report. The opacity of hedge funds was also said to have raised questions during the meme stock episode: some funds that had wagered against the stocks in question suffered losses when chatboard vigilants poured into them.

The answer to both episodes, which Fed and Ms. Brainard seemed to suggest, starts with better data.

“Archegos’ event highlights the limited visibility of hedge fund exposure and is a reminder that the measures available to leverage hedge funds may not capture key risks,” said Brainard. She added that the episode “underscores the importance of more detailed, more frequent disclosures”.

And while bubbles were high on the list of concerns, the Fed believed that underlying economic risks remained that could disrupt financial markets.

The coronavirus pandemic, which is under control in the US but continues to rage across much of the world, continues to pose risks to the system.

“Despite significant advances in vaccination, the perceived risks associated with the progression of the pandemic and its impact on the US and overseas economies remain relatively high,” the report said. “A worsening global pandemic could put a strain on the financial system in emerging economies and some European countries.”

Categories
Business

Biden Seizes on Weak Job Good points to Name for Fast Stimulus Motion

Others, like Texas Republican Michael C. Burgess, have emphasized the nation’s growing debt. Mr Burgess argued that Mr Biden’s plan would “add nearly $ 2 trillion to the deficit” before listing a number of complaints about the package, including the fact that it will send money to states he accuses of having poorly managed their budgets.

The main argument Republicans have made against the effort so far is that by failing to find Republican support, Mr Biden is cutting off his own campaign call to bring people together across party lines.

“After all the talk about unity,” said Senator Charles E. Grassley of Iowa, the Republican chief on the Finance Committee, “President Biden and the Democrats have taken the partisan route straight out of the gate.”

Mr. Biden and his staff opposed this criticism, claiming that “unity” refers to bringing together the voting public, not members of Congress.

“The president went on to unite the country and come up with ideas that would help address the crisis we are facing,” said Jen Psaki, White House press secretary, citing polls showing both parties’ support for demonstrate the plan by both parties. “He did not promise to unite the Democratic and Republican parties in one party in Washington.”

“This package is largely supported by the American public,” said Psaki. “That’s what people want. They want to see it’s over. They want those checks to get into the communities. They want these funds to go to schools. They want more money to distribute vaccines. “

Still, Mr Biden took the chance that Republicans would come aboard and allowed the possibility that his plans could be changed slightly to appease the moderates in both parties. This included recognition for advocating a restriction on who receives the $ 1,400 direct payments included in the proposal to ensure that those who earn more than $ 300,000 do not benefit. He did not specify what threshold he would accept to start the checks expiring, but made it clear that the starting amount would not change.

Categories
Business

Vaxart shares plunge on weak antibody response to oral vaccine

An experimental coronavirus oral vaccine showed promising results in an early clinical trial of 35 healthy adults, Vaxart of South San Francisco said on Wednesday. Despite the results, Vaxart’s stock fell about 57%.

Vaxart scientists divided volunteers between the ages of 18 and 54 into three groups. The first group received two low doses of the vaccine – called VXA-CoV2-1 – 29 days apart, while the remaining groups received a single low or high dose.

The vaccine, contained in a small tablet, produced a type of T cell responsible for killing virus-infected cells in about 75% of the volunteers who received a single low or high dose. The reported reactions are higher than with the vaccines from Moderna and Pfizer.

However, neutralizing antibodies were not detected in volunteers after a single dose, Vaxart said. Researchers believe that the antibodies play an important role in the defense of cells against the virus. The company said it is currently testing second-dose antibody responses after antibodies were detected in two-dose volunteers’ nasal swab samples.

Isaac Bogoch, an infectious disease specialist and professor at the University of Toronto, said the company’s shares could fall after the first dose due to the lack of neutralizing antibodies.

“The immune response is diverse,” he said, adding that one aspect of the immune response is to make antibodies, especially neutralizing antibodies. “While it is great to see that there seems to be a decent T-cell response, the lack of antibodies detected is problematic and can reduce the effectiveness of this vaccine.”

The company said no serious adverse events were reported in the Phase 1 study, with side effects generally being mild. Volunteers reported common side effects such as headache and fatigue, and there was a “slight increase” in the high-dose group of loose stool cases, the company said.

The data will be presented on Wednesday afternoon at the New York Academy of Sciences symposium.

“The most exciting thing about the [phase one data] is that we can get a very, very strong T-cell response even after one dose, “Sean Tucker, Vaxart’s chief scientific officer, told CNBC in a telephone interview, adding that T-cells do compared to antibodies fighting the virus is likely to be “underestimated”.

The biotech company said the vaccine has the potential to provide better protection against current and emerging strains of the virus than existing vaccines. Moderna, Johnson & Johnson and Novavax have announced in the past few days that their vaccines may be less effective against B.1.351, a highly contagious strain found in South Africa. US officials have raised concerns that Covid may continue to mutate and defy the protection of existing vaccines.

Vaxart’s vaccine contains DNA instructions for making the spike protein that allows the virus to enter human cells, as well as instructions for making the N protein, which is involved in other processes. Tucker said the inclusion of the N protein could cause the vaccine to retain its ability to work against emergent strains.

Many other vaccines under development chose spike protein as a “primary target,” he said. “But the problem with that [spike] Protein it definitely mutates more over time. We also added the N protein, which is highly conserved in the virus. “

According to Vaxart, the vaccine is the only oral tablet in the US that has been tested in humans. Similar technology is being used to develop vaccines against influenza and norovirus.

The company was investigated and investigated by the federal government late last year for allegedly exaggerating its involvement in Operation Warp Speed, former President Donald Trump’s vaccines and treatments program. A June press release said that “Vaxart’s Covid-19 vaccine has been selected for US government Operation Warp Speed,” which rocketed its stocks.

However, it found the company had received no federal government funding for vaccine doses and was only participating in preliminary U.S. studies to identify potential areas for possible Warp Speed ​​partnership and support, according to the New York Times.

Tucker told CNBC the company is in talks with the US and other governments to find possible ways to collaborate on its vaccine.

If Vaxart’s vaccine goes through other clinical trials and US approval, it could offer advantages over needle-based vaccines.

Dr. Paul Offit, a member of the FDA’s Advisory Committee on Vaccines and Allied Biological Products, said that an orally taken vaccine may be better accepted by the public who may be afraid of needles. Two US-approved Covid-19 vaccines – from Pfizer and Moderna – are injected into the arm and require two injections three to four weeks apart.

Vaxart said his vaccine is stable even at room temperature and does not require a freezer, which means it “can be stored and delivered to mass populations around the world”. In comparison, Pfizer’s vaccine must be stored in ultra-cold freezers that keep it between minus 112 and minus 76 degrees Fahrenheit. Moderna vaccine must be delivered between 13 and 5 degrees Fahrenheit.

Vaxart said the vaccine also doesn’t require any special medical training and can be taken at home. This will help comply with social distancing guidelines while relieving the burden on the health system.

The company said it was still critical whether it was single- or two-dose therapy.

A phase 2 study is expected “in the next few months,” Tucker said. In its “Fastest Accelerated Timeline,” the company expects Phase two and three studies to be completed by early 2022.

–CNBC’s Hugh Son contributed to this report.